Sustained tocilizumab-induced hypofibrinogenemia and thrombocytopenia. Comment on: "Tocilizumab-induced hypofibrinogenemia: A report of 7 cases" by Martis et al., Joint Bone Spine 2016, doi: 10.1016/j.jbspin.2016.04.008

Joint Bone Spine. 2017 Oct;84(5):649-650. doi: 10.1016/j.jbspin.2017.02.012. Epub 2017 Mar 28.
No abstract available

Keywords: Biologics; Hypofibrinogenemia; Interleukin-6; Large-vessel vasculitis; Tocilizumab.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized*
  • Humans
  • Receptors, Interleukin-6
  • Thrombocytopenia*

Substances

  • Antibodies, Monoclonal, Humanized
  • Receptors, Interleukin-6
  • tocilizumab